Back
uniQure NV 10K Form
Sell
11
QURE
uniQure NV
Last Price:
5.66
Seasonality Move:
11.25%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive QURE News And Ratings
See the #1 stock for the next 7 days that we like better than QURE
QURE Financial Statistics
Sales & Book Value
| Annual Sales: | $15.84M |
|---|---|
| Cash Flow: | $-33.32M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.99 |
| Price / Book: | 2.83 |
Profitability
| EPS (TTM): | -5.93000 |
|---|---|
| Net Income (TTM): | $-284.69M |
| Gross Margin: | $2.22M |
| Return on Equity: | -132.58% |
| Return on Assets: | -34.33% |
uniQure NV Earnings Forecast
Key uniQure NV Financial Ratios
- The Gross Profit Margin over the past 11 years for QURE is 13.98%.
- The Selling, General & Administrative Expenses for QURE have been equal to 470.81% of Gross Profit Margin.
- The Research & Development expenses have been 1,356.21% of Revenue.
- The Interest Expense is -13.47% of Operating Income.
- The Net Earning history of QURE is -1,947.09% of Total Revenues.
- Per Share Earnings over the last 13 years have been positive in 5 years.
uniQure NV Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | QURE |
| CUSIP: | N90064 |
| Website: | uniqure.com |
Debt
| Debt-to-Equity Ratio: | 1.06 |
|---|---|
| Current Ratio: | 7.36 |
| Quick Ratio: | 6.61 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
QURE Technical Analysis vs Fundamental Analysis
Sell
11
uniQure NV (QURE)
is a Sell
Is uniQure NV a Buy or a Sell?
-
uniQure NV stock is rated a Sell
The current uniQure NV [QURE] share price is $5.65. The Score for QURE is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.